\NBIFO Institut fir biologische Forschung GmbH - Kain PRIORITY

 

Addendum to Report P 0500/3237 97N0/8 Page 30
~ 12005
% 4 + VIRGO-CA
2 © : VIRGO-CC
3 O : 1R4F
~~ fae : without S9
z= 1000 —— : with sg
3S
=
o
5 00-1
bt
=
2 800

600 —|

400 -

200 +

 

8037/970926

 

 

 

 

0.0 02 O04 06 0.8 10
TPM DOSE (mg/plate)

Figure A2 Mutagenicity of TPM in Strain TA1537

Remarks: mean + SE, N = 12 plates
data see Tables A3, AG, A7, A12 to A15

Z8ZZb-Ly90z